Table 6.
Treatment of intracranial hypertension | Effect on neurological outcome | Effect on mortality |
---|---|---|
General prophylactic measures | ||
Intubation and mechanical ventilation | Unclear | Unclear |
BP – CPP optimization | Benefit | Benefit |
Body positioning | Unclear | Unclear |
Temperature control | Benefit | Benefit |
Prophylactic hypothermia | No benefit | No benefit |
Glycemic control | Benefit | Benefit |
Seizure prophylaxis | Unclear | Unclear |
Acute interventions | ||
Hyperventilation | Unclear | Unclear |
Hyperosmolar therapy | Unclear | Unclear |
Sedation and analgesia | Unclear | Unclear |
Barbiturates | Unclear | Unclear |
Therapeutic hypothermia | Possible benefit | Possible benefit |
Corticosteroids | No benefita | No benefita |
Resection of mass lesions | Unclear | Probable benefit |
Decompressive craniectomy | Unclear | Probable benefit |
CSF drainage | Unclear | Unclear |
Progesterone | No benefit | No benefit |
aExcept abscesses or neoplasms associated with vasogenic edema. BP: Blood pressure, CPP: Cerebral pressure perfusion, CSF: Cerebrospinal fluid